Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ICLR | ICON plc | -1.30% | 248.68 | 2.8% | $140.07m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -5.67% | 23.64 | 14.1% | $139.10m | |
| HZNP | Horizon Therapeutics Plc | -2.22% | 84.50 | 5.4% | $111.32m | |
| CTLT | Catalent, Inc. | -3.02% | 99.00 | 2.0% | $104.46m | |
| BHC | Bausch Health Cos., Inc. | -5.67% | 23.64 | 0.0% | $101.75m | |
| JAZZ | Jazz Pharmaceuticals Plc | -4.56% | 130.53 | 2.1% | $83.60m | |
| SAVA | Cassava Sciences, Inc. | -2.67% | 35.36 | 0.0% | $83.26m | |
| UTHR | United Therapeutics Corp. | -0.71% | 198.65 | 13.9% | $78.32m | |
| ZGNX | Zogenix, Inc. | -0.14% | 25.95 | 7.5% | $77.82m | |
| PRGO | Perrigo Co. Plc | -3.68% | 37.41 | 6.9% | $47.40m | |
| ARGX | argenx SE | -5.33% | 264.37 | 0.0% | $45.84m | |
| PCRX | Pacira Biosciences, Inc. | -3.96% | 60.92 | 9.8% | $27.54m | |
| BRBR | BellRing Brands, Inc. | 4.96% | 25.63 | 0.0% | $27.47m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | 0.41% | 11.04 | 9.5% | $22.92m | |
| SAGE | SAGE Therapeutics, Inc. | -3.82% | 36.75 | 7.6% | $17.22m |
Company Profile
argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.